Dr Reddys Laboratories BSE
4635.15 00.00 (1.04%)
Dr Reddys Laboratories share price as of last closing was 4635.15 on . As on date, the market capitalization of the company is Rs. 77,788.59 Crores and the book value of the same is Rs 1229.47 Crores. As per NSE data, in last traded details the quantity of shares traded for Dr Reddys Laboratories were . For the last 1 year period, Dr Reddys Laboratories share price saw 1-year high of 4987.00 and 1-year low of 3996.10. If you would have invested in Dr Reddys Laboratories share,... based on its share price your 1-year return on same would be 11.30%, on a 3-year investment period the return would be 17.80% and on a 5 year investment period the return would be 126.56%. In the financial year 2021-22, Dr Reddys Laboratories registered a net income of 22453.80 Cr. The company’s EPS stood at 131.16 while P/E Ratio stood at 29.77. While, analysing Share Price of a company is crucial, it is equally important to look at the Stock Performance, Fundamental Analysis, Financial Statements, Technical Analysis and Similar Stocks Comparision. It gives a sense of whether the company is growing, stable or deteriorating.
Markets Today
High | 4677.70 |
Open at | 4650.00 |
Volumes | 721 |
Lower Circuit | 2100.00 |
Low | 4644.80 |
Prev Close | 4635.15 |
Avg Price | 2205.85 |
Upper Circuit | 2400.00 |
Last Traded Details
Quantity | 92,923 |
Time | 13:46:05 |
Historical Performance
1-Year High | 4987.00 |
3-Year High | 5613.65 |
5-Year High | 5613.65 |
1-Year Low | 3996.10 |
3-Year Low | 3655.00 |
5-Year Low | 1972.00 |
1-Year Performance Indicator
Company Valuation
Market Cap (₹ Cr.) | 77,788.59 |
Book Value (₹) | 1229.47 |
Face Value (₹) | 5.00 |
P/E ratio | 29.77 |
Dividend Yield | 0.64 % |
Income Statements
Financial Year | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
All Expenditure (Cr) | 17,777.50 | 15,177.60 | 15,046.60 | 12,270.00 | 11,929.80 |
Operating Profit (Cr) | 0.00 | 22.10 | 17.97 | 23.04 | 17.55 |
EBIDTA (Cr) | 583.40 | 1,153.70 | 1,033.30 | 917.90 | 608.50 |
Profit Before Tax (Cr) | 3,061.40 | 2,883.50 | 1,885.70 | 2,335.80 | 1,350.40 |
Tax (Cr) | 878.90 | 931.90 | -140.30 | 385.80 | 438.00 |
Net Income (Cr) | 22,453.80 | 20,177.40 | 18,170.00 | 16,104.90 | 14,477.70 |
EPS (Cr) | 131.16 | 117.28 | 121.90 | 117.47 | 57.04 |
DPS (Cr) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
In Short term
In Long term
1 Week | 2.67% |
1 Month | -4.76% |
3 Months | 5.59% |
6 Months | 7.29% |
9 Months | 9.41% |
1 Year | 11.30% |
2 Years | -11.39% |
3 Years | 17.80% |
4 Years | 77.76% |
5 Years | 126.56% |
Dr Reddys Laboratories share price as of today is Rs. . The company has a market capitalization of Rs. 77,788.59 with a P/E ratio of 29.77. Over the past 1 year, Dr Reddys Laboratories’s share price has moved by 11.30% while the 5-year performance of the stock stands at 126.56%. You’d also be interested to know that Dr Reddys Laboratories's share price has a 1-year low of ₹ 3996.10 and a 1-year high of ₹ 4987.00.
The Dr Reddys Laboratories share hit a 1-year low of Rs. 3996.10 and a 1-year high of Rs. 4987.00. The current market capitalization of Dr Reddys Laboratories is Rs. 77,788.59. While past performance does not guarantee future performance, the past 1-year return of Dr Reddys Laboratories share was 11.30% while the 5-year return was 126.56%.
Dr Reddys Laboratories share price has moved by 11.30% in the past 1 year. During the same time, the stock hit a 1-year high of Rs. 4987.00 and a 1-year low of Rs. 3996.10. As far as the long-term trend is concerned, the 5-year performance of Dr Reddys Laboratories share stands at 126.56%
Dr Reddys Laboratories has a market capitalization of Rs. 77,788.59 as of today, while the share price stands at . The market cap has moved by 11.30% in the past year and 126.56% in the past 5 years.
As a stock investor, you’d be interested in knowing that Dr Reddys Laboratories share price has a P/E ratio of 29.77 as of today. Along with the P/E ratio, the book value of Dr Reddys Laboratories’s stock is Rs. 1229.47
Domestic Institutional Investors (DIIs) have a share in Dr Reddys Laboratories whereas Foreign Institutional Investors (FIIs) hold . The split between DIIs and FIIs is a crucial metric that stock investors track to gauge the market sentiment around the stock. The company’s promoters own of Dr Reddys Laboratories while non-promoters have a stake.
You can buy Dr Reddys Laboratories shares using the Dhan Trading App or Web Trading Platform. Follow these steps to get started:
If you have little money and want to buy Dr Reddys Laboratories stocks,Margin Trading Facility (MTF) is just the thing you need! MTF allows you to buy more with less. In fact, you can buy up to 4x more, which means you pay 25% and Dhan pays 75% for buying Dr Reddys Laboratories stocks.